iOS app Android app

Healthcare Vouchers

FDA and Vouchers for Neglected Diseases: A Bad Idea Gone Bad

Merrill Goozner | Posted 11.17.2011 | Healthy Living
Merrill Goozner

The unintended consequences of an ill-conceived incentive scheme will be on full display when Novartis goes before an FDA advisory committee seeking approval for its anti-malarial pill.